ESR1 and breast carcinoma: It is known that a relatively large number of nutritional and chemopreventive anti-cancer agents - including 4-hydroxytamoxifen - specifically up-regulate the expression of p27 in both estrogen receptor (ER)-positive and -negative human breast cancer cells in vitro [1,2].